Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays

被引:60
作者
Jeantet, D
Chemin, I
Mandrand, B
Tran, A
Zoulim, F
Merle, P
Trepo, C
Kay, A
机构
[1] INSERM, U271, F-69424 Lyon 03, France
[2] Ecole Normale Super, CNRS, UMR2142, Lyon, France
[3] Hop Archet 2, Serv Hepatogastroenterol, Nice, France
[4] Hop Hotel Dieu, Serv Hepatogastroenterol, Lyon, France
关键词
HBV; transfection; surface antigen expression; transcription; mutants;
D O I
10.1002/jmv.20119
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Occult hepatitis B virus (HBV) infections show little or no serological markers of viral infection, including the absence of hepatitis B surface antigen (HBsAg) which is the main marker of ongoing HBV infection. Such infections can be important in the context of blood and/or organ donations. To study whether mutations contribute to HBsAg seronegativity, S gene sequences from such patients were amplified and cloned. Sequencing revealed 12 clones from seven different patients which contained potentially important mutations. The sequences were subcloned into an expression vector and mutant HBsAgs were expressed in cell culture. The capacity of three HBsAg detection assays to recognise the mutant HBsAgs was studied. Three categories were found: mutant HBsAgs that are not recognised by the assays, those that are recognised as well as wild-type (WT) antigen and an intermediate category where detection of the mutant HBsAgs is reduced with respect to WT. Most of the isolates fall into the second category. Mutations can therefore contribute to HBsAg seronegativity in occult HBV infections, but in most cases the explanation is probably the low level of viral replication. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
[1]   TRANSMISSION OF SEROLOGICALLY SILENT HEPATITIS-B VIRUS ALONG WITH HEPATITIS-C VIRUS IN 2 CASES OF POSTTRANSFUSION HEPATITIS [J].
BAGINSKI, I ;
CHEMIN, I ;
HANTZ, O ;
PICHOUD, C ;
JULLIEN, AM ;
CHEVRE, JC ;
LI, JS ;
VITVITSKI, L ;
SNINSKY, JJ ;
TREPO, C .
TRANSFUSION, 1992, 32 (03) :215-220
[2]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[3]   Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation [J].
Bläckberg, J ;
Kidd-Ljunggren, K .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :992-997
[4]   PERSISTENCE OF HEPATITIS-B VIRAL-DNA AFTER SEROLOGICAL RECOVERY FROM HEPATITIS-B VIRUS-INFECTION [J].
BLUM, HE ;
LIANG, TJ ;
GALUN, E ;
WANDS, JR .
HEPATOLOGY, 1991, 14 (01) :56-62
[5]   VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].
CARMAN, WF ;
ZANETTI, AR ;
KARAYIANNIS, P ;
WATERS, J ;
MANZILLO, G ;
TANZI, E ;
ZUCKERMAN, AJ ;
THOMAS, HC .
LANCET, 1990, 336 (8711) :325-329
[6]   FULMINANT REACTIVATION OF HEPATITIS-B DUE TO ENVELOPE PROTEIN MUTANT THAT ESCAPED DETECTION BY MONOCLONAL HBSAG ELISA [J].
CARMAN, WF ;
KORULA, J ;
WALLACE, L ;
MACPHEE, R ;
MIMMS, L ;
DECKER, R .
LANCET, 1995, 345 (8962) :1406-1407
[7]   OCCULT HEPATITIS-B VIRUS AS SOURCE OF INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].
CHAZOUILLERES, O ;
MAMISH, D ;
KIM, M ;
CAREY, K ;
FERRELL, L ;
ROBERTS, JP ;
ASCHER, NL ;
WRIGHT, TL .
LANCET, 1994, 343 (8890) :142-146
[8]   Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease [J].
Chemin, I ;
Jeantet, D ;
Kay, A ;
Trépo, C .
ANTIVIRAL RESEARCH, 2001, 52 (02) :117-123
[9]   High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology [J].
Chemin, I ;
Zoulim, F ;
Merle, P ;
Arkhis, A ;
Chevallier, M ;
Kay, A ;
Cova, L ;
Chevallier, P ;
Mandrand, B ;
Trépo, C .
JOURNAL OF HEPATOLOGY, 2001, 34 (03) :447-454
[10]  
Chen WN, 2000, AM J GASTROENTEROL, V95, P1098